Plethora of New Products to be Showcased at Molecular Medicine TRI-CON 2011

Needham, MA (PRWEB) February 9, 2011

The Molecular Medicine TRI-CON, taking place February 23-25, at the Moscone Convention Center, San Francisco, CA, is the predominant event on the west coast focused on integrating the entire spectrum of drug development. It has experienced seven straight years of attendee growth, while maintaining a high quality audience. This year's event is on track to be another successful event. Spanning three days, the meeting is built around 5 scientific channels, encompassing 13 conferences, providing attendees more learning opportunities than ever before.

The 2011 event includes the New Product Pavilion, where 43 companies will showcase their new products to event delegates.

New Products Include:

Advanced Cell Diagnostics, Inc. - RNAscope? FFPE Assay Kit

Ambry Genetics - HiSeq 2000 Sequencing Services

ApoCell, Inc. - Cellx CTC Enrichment

Ariadne - Pathway Studio(R) version 8

Axxin - Diagnostic Instrumentation

Beta Pro LLC - Fresh and cryo-preserved human hepatocytes

Biogenex - X-Matrx

Bioneer - ExiPrep 16 Plus/ExiPrep 16 Pro, ExiSpin, SAMiRNA

BioScale - ViBE Protein Analysis Platform

Biosearch Technologies - Stellaris? FISH Probes

Covance???? - Covance Discovery and Translational Services

Cureline, Inc. - Human Biospecimens from patients with infectious diseases

Dotmatics, Ltd. - VORTEX

Dual Systems - Drug Profiling Service????

Enamine????- Advanced Collection 2011 for HTS

Esoterix Clinical Trials Service - Circulating Tumor Cells/Oncology Testing

Ezose Sciences Inc. - Advanced Glycan Analysis

fort?BIO - Octet RED96 System for Bench-top Protein Interactions Analysis

GENEGO - MetaCore?

Hardy Diagnostics - Culgenex Line

JMP Life Sciences - JMP Genomics and JMP Clinical

Linguamatics - I2E OnDemand

Lonza - Clonetics Primary Sensors: HUVEC Calcium biosensor

NanoInk Nano Biodiscovery - Angiogenesis Nanoarray Assay

NuGEN Technologies - Ovation? RNA-Seq FFPE System

Oasis Diagnostics Corporation - DNA?SA?, a new tool for salivary DNA collection

Omni International - Omni Bead Ruptor24

OpenEye Scientific Software - BROOD

Optibrium - StarDrop v5.0

Parthys Reverse informatics - Thematic Databases

QIAGEN - EGFR RGQ PCR Kit and EGFR Pyro Kit

Quantalife, Inc. - Droplet Digital PCR

ResearchDx - Contract Diagnostics Organization

Sigma Life Science - CompoZr? Oncology Cell Lines and Aldrich Market Select

Signal Genetics - "My PRS?"

Silicon Biosystems, Inc. - DEPArray? Platform

Simulations Plus, Inc. - MedChem Designer & ADMET Predictor Sites of Metabolism Module

Singulex - Erenna Immunoassay System

Studylog Systems, Inc. - Study Director v 1.8.19

SurExam Bio-Tech Co. Ltd - Biomarker Assay Solutions for Personalized Medicine

Thomson Reuters - Thomson Reuters

TriLink Biotechnologies - CleanAmp? 7-deaza-dGTP

Veridex, LLC - CellTracks? Circulating Melanoma Cell Kit

View list and description of new products at http://www.triconference.com/mmtc_content.aspx?id=104421&libID=104378

About Molecular Medicine TRI-CON

Molecular Medicine TRI-CON -- the flagship event of CHI - has built this year's event around 5 scientific channels, encompassing 13 conferences, providing attendees more learning opportunities than ever before. Featured channels include diagnostics, chemistry, informatics, biologics, cancer and executive. We are looking to provide attendees a more in depth experience into each of these seven areas of research and development. As the need for better information, new technologies, improved strategies and competitive intelligence becomes ever more acute, this event provides compelling research insight into the future of molecular medicine. In 2011, we expect 3,000 attendees, 1,200 participating companies, 160 exhibitors, 120+ posters, and representatives from over 38 countries. http://www.TriConference.com

About Cambridge Healthtech Institute

Cambridge Healthtech Institute (CHI) is the preeminent life science network for leading researchers and business experts from top pharmaceutical, biotech and academic organizations. CHI's portfolio of products includes Cambridge Healthtech Institute Conferences, Insight Pharma Reports, Barnett International, Cambridge Marketing Consultants, Cambridge Meeting Planners and Cambridge Healthtech's Media Group, which includes numerous e-newsletters as well as Bio-IT World magazine.

Founded in 1992, Cambridge Healthtech Institute strives to develop quality information sources that provide valuable new insights and competing points of view while offering balanced coverage of the latest developments. Basic research related to commercial implications is covered, with heavy emphasis placed on end-user insights into new products and technology as well as coverage on the strategy behind the business. http://www.chicorporate.com

Contact:

Tracey Fielding

Cambridge Healthtech Institute

Ph. 781-972-5429

tfielding (at) healthtech (dot) com

# # #

Cole Real Estate Investments Acquires $2.5 Billion of High-Quality Commercial Real Estate in 2011

Phoenix, AZ (PRWEB) January 19, 2012

Cole Real Estate Investments (Cole), one of the nation?s leading investors in high-quality, income-producing retail, office and industrial real estate assets, announced it successfully completed approximately $ 2.5 billion of real estate-related acquisitions in 2011. After acquiring more than $ 5 billion of core real estate the past two years, the firm finished the year with nearly $ 10 billion of total real estate assets under management.

Based on its strategy of acquiring real estate assets that are subject to long-term net leases with creditworthy tenants, Cole added approximately $ 1.8 billion of single-tenant commercial assets, including $ 1.1 billion of single-tenant retail properties and $ 744 million of single-tenant office and industrial assets, as well as $ 611 million of multi-tenant retail assets and $ 109.4 million of commercial mortgage-backed securities (CMBS), in 2011. Overall, these acquisitions included 283 total properties, more than 15.8 million square feet of commercial real estate, and nine CMBS bonds.

?Throughout the year, we saw high-quality assets come to market that fit our conservative investment strategy,? said Thomas W. Roberts, executive vice president and head of real estate investments at Cole. ?We attribute our success in acquiring $ 5 billion of core real estate over the past two years to our world-class acquisitions team, top-quality legal and underwriting procedures, extensive relationships across the commercial real estate brokerage community, and ability to close all-cash deals.?

Single-tenant retail acquisitions continued to be a primary focus for the firm. Noteworthy single-tenant retail acquisitions included a portfolio of 11 PetSmart stores in seven states for $ 74 million; 28 Walgreens in 17 states for $ 129.7 million; a Walmart Supercenter and Sam?s Club in Douglasville, GA, for $ 32.8 million; and a Whole Foods and Sierra Trading Post in Reno, NV, for $ 18.3 million. Other well-known retailers added to Cole?s single-tenant portfolio included Kohl?s, BJ?s Wholesale, Lowe?s, CVS, Best Buy, hhgregg, LA Fitness, Office Depot, California Pizza Kitchen, Advanced Auto and Hobby Lobby. Of the $ 1.1 billion of single-tenant retail assets acquired, approximately $ 387 million occurred via sale-leasebacks.?

Cole also continued to be an active acquirer in the multi-tenant anchored shopping sector, where the majority of the revenue is generated from anchor and junior anchor tenants. Notable acquisitions included Camp Creek Marketplace in Atlanta, GA, for $ 76.4 million; Oxford Exchange in Oxford, AL, for $ 45.5 million; Kyle Marketplace in Kyle, TX, for $ 45 million; Winchester Station in Winchester, VA, for $ 26.9 million; and Midtown Park in Anderson, SC, for $ 25.6 million. The firm also added its first asset in Alaska with the acquisition of Dimond Crossing in Anchorage for $ 14.4 million.

Cole?s portfolio of single-tenant, net-leased office and industrial assets grew to more than 70 properties by year-end. Notable acquisitions included the PetSmart headquarters in Phoenix for $ 102.5 million; a Walmart freezer/cold storage warehouse facility in Riverside, CA, for $ 91.5 million; a ConAgra Foods Distribution Facility in Milton, PA, for $ 28.5 million and the Medtronic office building in San Antonio, TX, for $ 32.9 million. The firm also completed the sale-leaseback of Apollo Group?s University of Phoenix office complex in Phoenix, AZ, for $ 170 million in March.

?Office and industrial acquisitions were a focus for Cole this past year, and we were able to acquire a number of strategic and mission-critical corporate assets that met our acquisition criteria,? explained Bob Micera, chief investment officer for office and industrial at Cole. ?We are extremely pleased to add creditworthy and well-known corporations such as PetSmart, ConAgra, Medtronic, Hanesbrands and Walmart to our growing portfolio of office and industrial assets.?

Cole continues to be one of the nation?s leading acquirers of quality commercial real estate assets. According to Real Capital Analytics, Cole ranked No. 1 in the U.S. for all single-tenant acquisitions and single-tenant retail acquisitions during the past five-year period, as well as No. 1 for single-tenant office acquisitions, No. 2 for all retail acquisitions, No. 3 for single-tenant industrial acquisitions (excluding joint ventures) and No. 5 for all property-type acquisitions (excluding joint ventures) for the past 12 months.

About Cole Real Estate Investments

Founded in 1979, Cole Real Estate Investments is one of the most active acquirers of core real estate assets, managing one of the country?s largest portfolios of retail properties. Cole primarily targets net-leased single-tenant and multi-tenant retail properties under long-term leases with high credit quality tenants, as well as single-tenant office and industrial properties. Cole executes a conservative investment and financing strategy designed to provide investors with the opportunity for stable current income and capital appreciation. Today, Cole-related entities own and manage more than 1,600 properties representing approximately 59.6 million square feet of commercial real estate in 47 states with a combined acquisition cost of nearly $ 10 billion.

Follow Cole on Twitter @ColeRealEstate and @ColeCapital.

Forward-Looking Statements

Certain statements in this press release may be considered forward-looking statements that reflect the current views of Cole Real Estate Investments and Cole?s management with respect to future events. Forward-looking statements about Cole?s plans, strategies and prospects are based on current information, estimates and projections; they are subject to risks and uncertainties, as well as known and unknown risks, which could cause actual results to differ materially from those projected or anticipated. Forward-looking statements are not intended to be a guarantee of any event, action, result, outcome or performance in future periods. Cole does not intend or assume any obligation to update any forward-looking statements, and the reader is cautioned not to place undue reliance on them.

# # #

More La Extensions Press Releases